| IPI00331214 - Cd36, PLATELET GLYCOPROTEIN 4. | |
|---|---|
| Uniprot Accession: Q9CT95 | |
| Uniprot ID: Q9CT95_MOUSE | |
| Mapping: Chr 5, 17297546 - 17340718 | |
| Entrez Gene: 12491 | |
| Entrez MapView: |
|
| MGI: MGI:107899 | |
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_4248) |
|---|
| Rat: Cd36, PLATELET GLYCOPROTEIN 4. |
| Mouse: Cd36, PLATELET GLYCOPROTEIN 4. |
| Rat: Cd36, CD36 ANTIGEN. |
| Human: CD36, PLATELET GLYCOPROTEIN 4. |
| Human: CD36, SIMILAR TO TRANSCRIPTION FACTOR DP-1. |
| Human: CD36, ANTIGEN CD36. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| integral to plasma membrane | C | TAS | ISS | |
| lysosome | C | RCA | ISS | |
| intracellular | C | IDA | ||
| caveola | C | IDA | ||
| membrane fraction | C | TAS | ISS | |
| integral to membrane | C | RCA | TAS ISS IEA | |
| microsome | C | IDA | ||
| mitochondrion | C | IDA | ||
| apical part of cell | C | IDA | ||
| membrane | C | IEA | IEA IEA | |
| sarcolemma | C | IDA | ||
| plasma membrane | C | IEA | IDA IDA IDA | |
| protein binding | F | IEA | IEA | IPI IEA |
| receptor activity | F | IEA | IEA | IGI IEA |
| fatty acid binding | F | TAS | ||
| fatty acid oxidation | P | IMP IMP | ||
| fatty acid transport | P | IEP IMP IDA | ||
| cell adhesion | P | TAS IEA | RCA | ISS ISS IEA |
| long-chain fatty acid transport | P | TAS IMP IMP | ||
| long-chain fatty acid metabolic process | P | IMP | ||
| lipid metabolic process | P | NAS | ISS | |
| transport | P | IEA | IEA | IEA |
| blood coagulation | P | TAS | ISS | |
| triacylglycerol metabolic process | P | IMP | ||
| fatty acid metabolic process | P | NR | IDA ISS IMP IMP |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| homeostasis/metabolism phenotype | MP | Un | ||
| cardiovascular system phenotype | MP | Un | ||
| immune system phenotype | MP | Un | ||
| vision/eye phenotype | MP | Un | ||
| life span-post-weaning/aging | MP | Un | ||
| obese | N | IED | ||
| hyperlipidemia | N | IED | ||
| impaired glucose tolerance | N | IED | ||
| increased mean platelet volume | N | ISS | ||
| increased blood pressure | N | IED | ||
| cardiac hypertrophy | N | ISS | ||
| insulin resistance | N | IEDIEDIED | ||
| abnormal circulating free fatty acids level | N | IEDIED |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Blood Platelet Disorders | D | ISS | ||
| Osteoarthritis | D | ISS | ||
| Insulin Resistance | D | IEDIAGP |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| ECM-receptor interaction (04512) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| PPAR signaling pathway (03320) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Adipocytokine signaling pathway (04920) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Hematopoietic cell lineage (04640) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |